Tue Dec 23 04:20:00 UTC 2025: ## Gujarat Kidney & Super Speciality Launches ₹250.8 Crore IPO, Oversubscribed on Day One

Vadodara, December 22, 2025 – Gujarat Kidney and Super Speciality, a leading super speciality healthcare provider based in Vadodara, Gujarat, launched its Initial Public Offering (IPO) today, aiming to raise ₹250.8 crore. The IPO, a book-building issue, consists entirely of a fresh issue of 2.20 crore shares.

Prior to the public offering, the company successfully raised ₹100 crore from anchor investors on December 19, 2025, demonstrating strong investor confidence.

The IPO price band is set at ₹108-₹114 per share, with a lot size of 128 shares, requiring a minimum investment of ₹14,592 for retail investors. The IPO will remain open for subscription until December 24, 2025.

Subscription Status on Day One Shows Strong Retail Interest:

Early indicators suggest strong investor interest, particularly from retail investors. By the end of the first day of trading, the IPO was subscribed 1.54 times overall. Retail Individual Investors (RIIs) led the charge, subscribing 5.07 times their allocated portion. Non-Institutional Investors (NIIs) subscribed 1.98 times, while Qualified Institutional Buyers (QIBs) showed more measured interest, subscribing 0.34 times their allocation.

Use of Funds and Tentative Timetable:

The company plans to utilize the net proceeds from the fresh issue for various objectives, details of which are available in the IPO prospectus.

The basis of allotment is expected to be finalized by December 26, 2025, and the tentative listing date on both the BSE and NSE is December 30, 2025.

Nirbhay Capital Services Private Limited is serving as the Book Running Lead Manager for the IPO, with MUFG Intime India Private Limited acting as the Registrar.

Company Background:

Gujarat Kidney and Super Speciality Hospital is a well-established healthcare facility in Vadodara, offering a comprehensive range of medical and surgical services. The hospital specializes in nephrology, urology, renal transplantation, and other high-end specialities, in addition to providing treatment in general medicine, surgery, cardiology, neurology, oncology, gastroenterology, orthopaedics, and other allied disciplines.

Market Sentiment:

According to media reports, the Grey Market Premium (GMP) for Gujarat Kidney and Super Speciality shares is currently reported at ₹7 over the IPO price, suggesting positive market sentiment.

Disclaimer: This news is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence before making any investment decisions.

Read More